肺癌合并活动性肺结核临床诊治分析

Clinical Diagnosis and Treatment of Active Tuberculosis and Lung Cancer

目的分析并讨论肺癌合并活动性肺结核的临床特征及诊治。方法选取2013年2月-2014年3月我院收治的肺癌合并活动性肺结核患者15例,对其临床资料进行回顾性分析,观察、总结患者的临床表现,分析总结诊治方法及其疗效。结果 15例中生存超过2年的有3例,1年期生存率为20.00%;生存超过1年的有7例,1年期生存率为46.67%;在2-9个月内死亡5例,占33.33%。结论完善相关检查避免误诊,尽早开展手术、化疗、抗结核综合治疗,是提高肺癌合并活动性肺结核患者生存率,改善预后的关键。

Objective To analyze and discuss with the clinical features of active tuberculosis and lung cancer diagnosis and treatment. Methods From February 2013 to March 2014, 15 cases of lung cancer combined active tuberculosis patient of our hospital, the clinical data were retrospectively analyzed, observation, the summary of the patient＇s clinical manifestations, analysis summarizes the treatment methods and curative effect. Results 15 cases of survival more than 2 years of the 3 cases, one-year survival rate was 20.00%, Live more than 1 year in 7 cases, one-year survival rate was 46.67%, Die in 2 to 9 months in 5 cases, accounting for 33.33%. Conclusion Perfecting the relevant examination to avoid misdiagnosis, as soon as possible to carry out surgery, chemotherapy, anti-tuberculosis treatment, is to improve the merger in patients with active tuberculosis lung cancer survival rates, the key to improve prognosis.